  | Kindt, N., Thayse, K., Dalil, N., Trelcat, A., & Carlier, S. (May 2024). Does female sex matter in a chronic intermittent hypoxia mouse model? Journal of Molecular and Cellular Cardiology, 190, 76 - 78. doi:10.1016/j.yjmcc.2024.04.005  Peer reviewed vérifié par ORBi |
  | Thayse, K., Brogniet, S., Carlier, S., Kindt, N., & Tassin, A. (13 February 2020). Comparison of Vascular Cell Adhesion Molecule-1 (VCAM-1) expression following stimulation with TNF alpha on human umbilical vein endothelial cells and EA.hy926 cells for atherosclerosis research [Paper presentation]. 39th Annual Belgian Society of Cardiology Meeting, Bruxelles, Unknown/unspecified. |
 | Seminerio, I., Descamps, G., Dupont, S., de Marrez, L., Laigle, J.-A., Lechien, J., Kindt, N., Journe, F., & Saussez, S. (15 February 2019). Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma. Cancers, 11 (227). doi:10.3390/cancers11020227 Peer reviewed vérifié par ORBi |
 | Kindt, N., Descamps, G., Lechien, J., Remmelink, M., Colet, J.-M., Wattiez, R., Berchem, G., Journe, F., & Saussez, S. (02 February 2019). Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine, 1#0 (8). Peer reviewed vérifié par ORBi |
Kindt, N., Journe, F., Ghanem, G., & Saussez, S. (18 December 2017). Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas. International Journal of Molecular Sciences, 18 (12). Peer reviewed vérifié par ORBi |
Lechien, J., Nassri, A., Kindt, N., Brown, D., Journe, F., & Saussez, S. (2017). Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review. Head and Neck. Peer reviewed vérifié par ORBi |
Kindt, N., Descamps, G., Seminerio, I., Bellier, J., Lechien, J., Mat, Q., Pottier, C., Delvenne, P., Journe, F., & Saussez, S. (22 September 2017). High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma [Poster presentation]. Second symposium of the ULB-cancer research center, Bruxelles, Belgium. |
Seminerio, I., Kindt, N., Descamps, G., Bellier, J., Lechien, J., Mat, Q., Pottier, C., Delvenne, P., Journe, F., & Saussez, S. (18 May 2017). Stromal FoxP3-positive T Cell Number Combined to Tumor Stage Improves Prognosis in Head and Neck Squamous Cell Carcinoma [Poster presentation]. BIT's 10th Annual World Cancer Congress 2017, Barcelona, Spain. |
Buxant, F., Kindt, N., Noel, J., Laurent, G., & Saussez, S. (16 March 2017). Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy. Breast Cancer, 9, 171-175. Peer reviewed vérifié par ORBi |
Kindt, N., Descamps, G., Seminerio, I., Bellier, J., Lechien, J., Mat, Q., Pottier, C., Delvenne, P., Journe, F., & Saussez, S. (08 March 2017). High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma. Oral Oncology, 67, 183-191. Peer reviewed vérifié par ORBi |
Kindt, N., Descamps, G., Seminerio, I., Bellier, J., Lechien, J., Pottier, C., Larsimont, D., Journe, F., Delvenne, P., & Saussez, S. (01 November 2016). Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas. Oral Oncology, 62 (2016), 1-10. Peer reviewed vérifié par ORBi |
 | Richard, V., Conotte, R., Kindt, N., Saussez, S., & Colet, J.-M. (07 October 2016). Macrophage migration inhibitory factor (MIF) involvement in breast cancer cell metabolism: A 1H-NMR spectroscopy evaluation [Poster presentation]. ESMO 2016 Congress From disease treatment to patient care, Copenhagen, Denmark. |
Kindt, N., Journe, F., Laurent, G., & Saussez, S. (02 August 2016). Involvement of macrohage migration inhibitory factor in cancer and novel therapeutic targets (Review). Oncology Letters, 12, 2247-2253. Peer reviewed vérifié par ORBi |
Descamps, G., Karaca, Y., Lechien, J., Kindt, N., Decaestecker, C., Remmelink, M., Larsimont, D., Andry, G., Hassid, S., Rodriguez, A., Khalife, M., Journe, F., & Saussez, S. (01 July 2016). Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients. Journal of Cancer Research and Clinical Oncology, 152 (10), 2185-2196. Peer reviewed vérifié par ORBi |
Descamps, G., Karaca, Y., Lechien, J., Kindt, N., Decaestecker, C., Remmelink, M., Andry, G., Rodriguez, A., Khalife, M., Journe, F., & Saussez, S. (30 January 2016). The classical risk factors predict recurrence and survival after concomitant chemoradiotherapy in advanced head and neck cancer patients unlike the HPV status [Poster presentation]. BACR Annual Meeting, ULB Erasme, Belgium. |
Kindt, N., Bol, V., Schneider, K., Grégoire, V., & Saussez, S. (22 September 2015). Relationship between Macrophage migration Inhibitory Factor and HPV infection in head and neck squamous cell carcinoma [Poster presentation]. 2nd International Symposium of the cancer research center of Lyon, Lyon, France. |
 | Kindt, N., Lechien, J., Nonclercq, D., Laurent, G., & Saussez, S. (11 June 2014). Involvement of CD74 in head and neck squamous cell carcinomas. Journal of Cancer Research and Clinical Oncology, 140 (6), 937-947. Peer reviewed vérifié par ORBi |
Lechien, J., Kindt, N., Costa, P., Preillon, J., Chantrain, G., Laurent, G., & Saussez, S. (01 April 2013). MIF in Head and Neck cancer: a new therapeutic target ? : Le MIF dans les cancers des voies aéro-digestives supérieures : une nouvelle thérapie ciblée ? Revue de Laryngologie - Otologie - Rhinologie, 134 (2), 67-74. Peer reviewed vérifié par ORBi |
Kindt, N., Preillon, J., Laurent, G., Gabius, H.-J., Decaestecker, C., Johnson, B., Chantrain, G., & Saussez, S. (14 February 2013). Involvement of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma [Poster presentation]. 1st Symposium of Cancer Research Center of Lyon, Lyon, France. |
 | Richard, V., Conotte, R., Kindt, N., Faverly, D., Laurent, G., Colet, J.-M., Noël, J. C., & Saussez, S. (29 January 2013). INTEGRATING PROTEOMICS AND METABONOMICS FOR A BETTER UNDERSTANDING OF HUMAN BREAST CANCER BIOLOGY [Poster presentation]. 1ère journée des doctorants en Sciences Biomédicales et Pharmaceutiques, Mons, Belgium. |
| Kindt, N., Lechien, J., Journé, F., Ghanem, G., Duvillier, H., Laurent, G., & Saussez, S. (29 January 2013). Involvement of CD74 in head and neck squamous cell carcinoma [Paper presentation]. 1ère journée des doctorants en Sciences Biomédicales et Pharmaceutiques, Mons, Belgium. |
Kindt, N., Preillon, J., Kaltner, H., Gabius, H.-J., Chevalier, D., Rodriguez, A., Johnson, B., Megalizzi, V., Decaestecker, C., Laurent, G., & Saussez, S. (25 January 2013). Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies. Journal of Cancer Research and Clinical Oncology, 139 (5), 727-737. Peer reviewed vérifié par ORBi |
 | Kindt, N., Laurent, G., Nonclercq, D., Journé, F., Ghanem, G., Duvillier, H., Gabius, H.-J., Lechien, J., & Saussez, S. (12 January 2013). Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells. International Journal of Oncology, 43 (1), 185-193. Peer reviewed vérifié par ORBi |
Kindt, N., Lechien, J., Decaestecker, C., Rodriguez, A., Chantrain, G., Remmelink, M., Laurent, G., Gabius, H.-J., & Saussez, S. (12 October 2012). Expression of Macrophage Migration-Inhibitory Factor is Correlated with Progression in Oral Cavity Carcinomas. Anticancer Research, 32 (10), 4499-4506. Peer reviewed vérifié par ORBi |
 | Cludts, S., Decaestecker, C., Johnson, B., Lechien, J., Leroy, X., Kindt, N., Kaltner, H., André, S., Gabius, H.-J., & Saussez, S. (02 June 2010). Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma. Anticancer Research, 30, 3313-3320. Peer reviewed vérifié par ORBi |